Literature DB >> 28702138

Prevalence and clinical features of Cryptosporidium infection in hemodialysis patients.

Mohammad Ali Mohaghegh1, Seyed Hossein Hejazi1,2, Mohsen Ghomashlooyan1, Hamed Kalani1, Farzaneh Mirzaei1,3, Mehdi Azami2.   

Abstract

AIM: This cross-sectional study aims to assess the prevalence of Cryptosporidium in hemodialysis patients compared with healthy individuals in central Iran from August 2014 to January 2015.
BACKGROUND: Cryptosporidiosis is a major cause of acute and persistent diarrhea with significant morbidity and mortality in immunocompromised patients such as those undergoing renal dialysis.
METHODS: Three stool samples were collected from 330 hemodialysis patients and 150 healthy individuals on 3 consecutive days. The samples were screened for Cryptosporidium infection using formalin-ether sedimentation and modified Ziehl-Neelsen staining. Demographic variables as well as risk factors were recorded.
RESULTS: Out of 330 dialysis patients and 150 healthy individuals, 10 (3%) and 1 (0.7%) were infected with Cryptosporidium, respectively. We found statistically significant differences between infection and place of residency, hygiene status, education level, diarrhea, and abdominal pain in the two groups (p<0.05). On the other hand, there was no relationship between infection and sex, contact with domestic animals, fever, vomiting, nausea, flatulence, anorexia, duration of dialysis and underlying disorders in the two groups. Also, there was a statistically significant difference between age and infection in hemodialysis patients (p=0.003). A higher infection rate was observed in patients under 20 years of age.
CONCLUSION: Risk factors for Cryptosporidium infection must be controlled. We strongly recommended that stool samples from such patients, especially those with severe or prolonged diarrhea, should be examined with modified Ziehl-Neelsen staining for appropriate and timely treatment.

Entities:  

Keywords:  Cryptosporidium; Diarrhea; Hemodialysis; Immunocompromised patients; Prevalence

Year:  2017        PMID: 28702138      PMCID: PMC5495902     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol Bed Bench        ISSN: 2008-2258


Introduction

Cryptosporidium is a coccidian protozoan parasite with gastrointestinal manifestations in humans and animals; it is predominantly transmitted via the fecal-oral route (1). Numerous Cryptosporidium species, including C. hominis, C. parvum, C. meleagridis, C. canis, C. wrairi, C. suis, C. felis, C. andersoni and C. muris, can infect humans (2-5). Cryptosporidiosis is spread worldwide and its prevalence is high in developing countries (6). Cryptosporidium causes watery or mucoid diarrhea with abdominal pain that may persist from a few days to much longer (7). Although benign and self-limiting in immunocompetent individuals, cryptosporidiosis is a major cause of acute and persistent diarrhea with significant morbidity and mortality in immunocompromised patients such as those with HIV/AIDS, malignancies, organ transplantation and those undergoing renal dialysis (1, 8, 9). Chronic renal failure (CRF) is one of the causes of insufficient immune response to infections. In patients undergoing hemodialysis, sepsis-related death is 100 to 300-times more frequent than healthy individuals (10). Progressive and irreversible loss of renal functions causes uremia (11), which impairs T-cell activation and compromises antibody production (12). Malnutrition and vitamin deficiency occur due to either inadequate intake or loss during dialysis. Also during dialysis, prealbumin is decreased and C-reactive protein is increased in patients (13-15). Repeated per-dialysis hypotension, with the activation of nitric oxide, platelet dysfunction and anemia result in specific immunological changes (16, 17). Leukocyte dysfunction, increased susceptibility to opportunistic infection such as Cryptospodidium spp., and impaired neutrophil activity (phagocytosis, migration, bactericidal) also occur in hemodialysis patients (18, 19). The present study aims to assess the prevalence of Cryptosporidium spp. in a group of hemodialysis patients and compared with healthy individuals in central Iran.

Methods

This cross-sectional study was conducted from August 2014 to January 2015 at four hospitals (Shariati, Nor, Al-Zahra, Hojjatieh) in Isfahan, central Iran. Stool specimens were collected from 330 hemodialysis patients and 150 healthy individuals (i.e. individual’s working in many wards of the above hospitals) as the control group. Informed consent was obtained from all patients for participation in the study and the study was conducted in accordance with the principles of the Declaration of Helsinki. Demographic variables, as well as risk factors, were recorded, including sex, age, place of residence, close contact with domestic animals, hygiene status, education, fever, gastrointestinal symptoms, duration of dialysis and underlying disorders. Three stool samples were collected from each participant in sterile plastic containers on 3 consecutive days. The samples were preserved in 10% formalin and kept in a cool and dry place until examination. The stool samples were concentrated using formalin-ether method. From each sample, a separate thin microscopic smear was prepared and allowed to dry in air. The smears were fixed with absolute methanol and then stained by cold modified Ziehl-Neelsen staining. Finally, the air-dried slides were examined with light microscopy for presence of Cryptosporidium spp. oocysts at 1000× magnification. The data were analyzed with chi-square test, and P-values less than 0.05 were considered statistically significant.

Results

Out of 330 dialysis patients and 150 healthy individuals, 10 (3%) and 1 (0.7%) were infected with Cryptosporidium spp., respectively. The mean age was 33.1 ± 12 years in the infected patients group and 34 ± 11 years in the infected healthy group. We found a statistically significant difference in age among the hemodialysis patients; a higher infection rate was observed in patients under 20 years of age. There was a significant correlation between the prevalence rate of Cryptosporidium infection and place of residence in the patient and control groups (p<0.05). Cryptosporidium infection rate in the rural population (13.7%) was higher than the urban population (2.3%) in the hemodialysis patients group. A similar condition was seen in healthy individuals group. Five (4%) of hemodialysis patients and 1 (1.8%) of healthy individuals who were infected with Cryptosporidium had diarrhea which indicates a significant difference. Also, there was a statistically significant difference between abdominal pain and Cryptosporidium infection (p=0.028). Demographic characteristics of hemodialysis patients and healthy individuals infected with Cryptosporidium spp Clinical features of hemodialysis patients and healthy individuals infected with Cryptosporidium spp The prevalence rate of Cryptosporidium infection did not correlate with sex, contact with domestic animals, fever, vomiting, nausea, flatulence, anorexia, duration of dialysis and underlying disorders in either group (p>0.05). The main demographic and clinical parameters of the study groups are shown in tables 1 and 2. The underlying disorders and duration of dialysis in hemodialysis patients are shown in Table 3.
Table 1

Demographic characteristics of hemodialysis patients and healthy individuals infected with Cryptosporidium spp

Case group (n=330)
Control group (n=150)
TotalInfected n (%) P valueTotalInfected n (%) P value
Sex:
Male Female2071236 (2.9)4 (3.3)0.24390601 (1.2)0 (0)0.186
Age (year)
≤ 20 21-65 ≥ 651301001005 (3.9)2 (2)3 (3)0.0035050501 (2)0 (0)0 (0)0.061
Place of residency
Urban Rural308227 (2.3)3 (13.7)0.001138121 (0.7)0 (0)0.003
Contact with domestic animals
Yes No1481824 (2.8)6 (3.3)0.261491010 (0)1 (0.9)0.183
Hygiene status
Excellent Moderate Bad21090303 (1.4)3 (4.5)3 (10)0.0036060300 (0)0 (0)1 (3.4)0.034
Education
Illiterate Elementary education High school diploma or higher55951805 (9.1)3 (3.2)2 (1.2)0.0021834981 (5.6)0 (0)0 (0)0.034
Table 2

Clinical features of hemodialysis patients and healthy individuals infected with Cryptosporidium spp

Case group (n=330)
Control group (n=150)
TotalInfected n (%)P valueTotalInfected n (%)P value
Fever
Yes No1052253 (2.9)7 (3.2)0.8254960 (0)1 (1.1)0.15
Diarrhea
Yes No1252055 (4)5 (2.5)0.0393571 (1.1)0 (0)0.01
Vomiting
Yes No1681626 (2.4)4 (2.5)0.3551450 (0)1 (0.7)0.17
Nausea
Yes No1232073 (2.5)7 (3.4)0.56411090 (0)1 (1.3)0.15
Flatulence
Yes No281496 (2.2)(8.2)0.2668820 (0)1 (1.5)0.83
Anorexia
Yes No245856 (2.5)4 (4.8)0.3862880 (0)1 (1.2)0.35
Abdominal pain
Yes No2051077 (3.5)3 (2.9)0.03481021 (2.1)0 (0)0.03
Table 3

Disorder and duration of dialysis recorded in hemodialysis patients infected with Cryptosporidium spp

Case group (n=330)
TotalInfected n (%) P value
Duration of dialysis (month)
1-12 13-24 ≥ 251011041254 (3.9)3 (2.9)3 (2.4)0.84
Underlying disorders
Diabetes Hypertension Polycystic kidney Glomerulonephritis Renal stone1882048956616 (3.2)9 (4.5)4 (4.5)2 (3.6)1 (1.7)0.68

Discussion

Studies have shown that damage to the immune system in patients with CRF often leads to increased susceptibility to bacterial infections, mainly involving the respiratory, digestive, urinary systems and skin. These infections are responsible for between 14-40% of deaths in these patients (10, 20). In addition, studies have reported high infection rate with Cryptosporidium spp. in hemodialysis patients (21-23). Disorder and duration of dialysis recorded in hemodialysis patients infected with Cryptosporidium spp In the present study, the rate of infection with Cryptosporidium was 3%. Previous studies have reported the prevalence of cryptosporidiosis in hemodialysis patients from different regions of the world to be 20.7%, 15%, 26.4% and 11.5% in Turkey, Egypt, Brazil and Iran, respectively (21, 22, 24, 25). There was a statistically significant difference between age and Cryptosporidium infection in the patients group (p=0.003) and a higher infection rate was observed in patients under 20 years of age, while there was no relationship between age and Cryptosporidium infection in the healthy individuals (p=0.061). We found a statistically significant difference in age among the hemodialysis patients. Our result is similar to a previous study (26) and is inconsistent with the findings of Raja et al. (2014) and Seyrafian et al. (2006). Malnutrition is a sign in hemodialysis patients (13) that causes geophagia, especially in children, which raises the risk of infection with Cryptosporidium spp. (28). In the present study, there was a significant correlation between the prevalence rate of Cryptosporidium infection and place of residence in the patient and control groups (p<0.05). The results of recent studies are similar to our finding (26). Socioeconomic status and close contact with domestic animals, especially sheep and cattle, in rural residents increase the risk of infection with intestinal parasites (29). Sheep and cattle play an important role in the spread of infection and an increased risk of infection with Cryptosporidium parvum in humans (30). In our study, the poverty and illiteracy status were considered as two risk factors in relation to Cryptosporidium infection in hemodialysis patients that are similar to the result of a recent study (26). Contrary to this result was a study from Pakistan which examined 644 fecal specimens from renal transplant patients with acute diarrhea and found no significant difference between Cryptosporidium infection and age, gender or duration of dialysis (27). The insufficient information regarding risk factors in illiterate patients, such as consumption of unsafe water and food, is associated with an increased risk of the acquisition of cryptosporidial infection (31). Gastrointestinal symptoms, especially diarrhea (chronic or acute), nausea, hyporexia, vomiting, and abdominal pain are very common in patients undergoing dialysis (32). A high prevalence of diarrhea was observed in the hemodialysis patients with Cryptosporidium in our study. Cryptosporidiosis is a major cause of acute and persistent diarrhea, especially in immunocompromised individuals, malnourished children and the elderly in developing countries (6). Seyrafian et al. (2006) compared the prevalence rate of Cryptosporidium infection in hemodialysis patients and 2 control groups (i.e., their healthy family members and normal population). Stool specimens of 104 adult outpatient chronic hemodialysis patients, their 91 healthy family members, and 140 healthy individuals were examined for the presence of Cryptosporidium oocysts using a modified acid-fast staining method. Twelve (11.5%) dialysis patients were infected with Cryptosporidium. This was significantly higher than 4 (4.4%), and 5 (3.6%) cases in the 2 control groups, respectively (p < 0.05). There was no significant difference between the 2 control groups. The prevalence rate of Cryptosporidium infection did not correlate with patients' sex, age, duration of dialysis, history of kidney transplantation, or history of taking immunosuppressive drugs. However, it was significantly higher in diabetics vs. nondiabetics (19.4% vs. 8.3%, respectively, p < 0.05). The results indicate that the prevalence rate of Cryptosporidium infection is considerably higher in dialysis patients than the general population. Moreover, dialyzed diabetic patients had the highest rate of infection. These finding are in contrast with our results. In this study, diabetes mellitus and hypertension were detected in 57% and 61.8% patients of the hemodialysis group, respectively. Diabetes mellitus is the second major cause of CRF that leads to simultaneous impairment of other organs and the immune system. There is a high prevalence of hypertension in CRF patients, depending on the type of nephropathy, degree of renal failure, advanced age and the presence of diabetes (33). Strict control of blood pressure, hyperglycemia and glycosuria are essential for avoiding and delaying the decrease in renal function (33, 34). Finally, according to the findings, Cryptosporidium is an opportunistic protozoan and a causative agent of prolonged diarrhea in immunocompromised patients, such as those undergoing hemodialysis. Therefore, it is necessary to control risk factors and adopt preventive measures against infection. We strongly recommended that the stool samples of these patients, especially those with severe or prolonged diarrhea, should be examined with cold modified Ziehl-Neelsen staining for appropriate and timely treatment.
  23 in total

1.  Cu/Zn ratios are associated with nutritional status, oxidative stress, inflammation, and immune abnormalities in patients on peritoneal dialysis.

Authors:  Chih-Hung Guo; Pei-Chung Chen; Maw-Sheng Yeh; Der-Yun Hsiung; Chia-Liang Wang
Journal:  Clin Biochem       Date:  2011-01-09       Impact factor: 3.281

Review 2.  Neutrophil dysfunction and infection risk in end-stage renal disease.

Authors:  Michel Chonchol
Journal:  Semin Dial       Date:  2006 Jul-Aug       Impact factor: 3.455

3.  Intestinal spore-forming protozoa among patients suffering from chronic renal failure.

Authors:  M S Ali; L A Mahmoud; B E Abaza; M A Ramadan
Journal:  J Egypt Soc Parasitol       Date:  2000-04

4.  Prevalence of Cryptosporidium infection in hemodialysis patients.

Authors:  Nuran Turkcapar; Sim Kutlay; Gokhan Nergizoglu; Teslime Atli; Neval Duman
Journal:  Nephron       Date:  2002-03       Impact factor: 2.847

5.  Mortality caused by sepsis in patients with end-stage renal disease compared with the general population.

Authors:  M J Sarnak; B L Jaber
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

Review 6.  Oxidative stress and inflammation: Implications in uremia and hemodialysis.

Authors:  Carmelo Libetta; Vincenzo Sepe; Pasquale Esposito; Francesco Galli; Antonio Dal Canton
Journal:  Clin Biochem       Date:  2011-07-12       Impact factor: 3.281

7.  Immunologic function and survival in hemodialysis patients.

Authors:  P L Kimmel; T M Phillips; S J Simmens; R A Peterson; K L Weihs; S Alleyne; I Cruz; J A Yanovski; J H Veis
Journal:  Kidney Int       Date:  1998-07       Impact factor: 10.612

Review 8.  T cells and B cells in chronic renal failure.

Authors:  B Descamps-Latscha; L Chatenoud
Journal:  Semin Nephrol       Date:  1996-05       Impact factor: 5.299

9.  Infection by Cryptosporidium parvum in renal patients submitted to renal transplant or hemodialysis.

Authors:  P P Chieffi; Y A Sens; M A Paschoalotti; L A Miorin; H G Silva; P Jabur
Journal:  Rev Soc Bras Med Trop       Date:  1998 Jul-Aug       Impact factor: 1.581

10.  Epidemiology, clinical, immune, and molecular profiles of microsporidiosis and cryptosporidiosis among HIV/AIDS patients.

Authors:  Roger Wumba; Benjamin Longo-Mbenza; Jean Menotti; Madone Mandina; Fabien Kintoki; Nani Hippolyte Situakibanza; Marie Kapepela Kakicha; Josue Zanga; Kennedy Mbanzulu-Makola; Tommy Nseka; Jean Pierre Mukendi; Eric Kendjo; Jean Sala; Marc Thellier
Journal:  Int J Gen Med       Date:  2012-07-19
View more
  5 in total

Review 1.  Molecular Epidemiology of Human Cryptosporidiosis in Low- and Middle-Income Countries.

Authors:  Xin Yang; Yaqiong Guo; Lihua Xiao; Yaoyu Feng
Journal:  Clin Microbiol Rev       Date:  2021-02-24       Impact factor: 26.132

2.  Cryptosporidiosis among Hemodialysis Patients in Jordan: First Preliminary Screening Surveillance.

Authors:  AbdelRahman M Zueter; Nawal S Hijjawi; Khaled N Hamadeneh; Maysa M Al-Sheyab; Amal M Hatamleh
Journal:  Trop Med Infect Dis       Date:  2019-10-18

Review 3.  Health risk of travel for chronic kidney disease patients.

Authors:  Yoshitaka Furuto; Mariko Kawamura; Akio Namikawa; Hiroko Takahashi; Yuko Shibuya
Journal:  J Res Med Sci       Date:  2020-03-18       Impact factor: 1.852

4.  Frequency and Molecular Identification of Cryptosporidium Species among Immunocompromised Patients Referred to Hospitals, Central Iran, 2015-16.

Authors:  Shahrokh Izadi; Mohammad Ali Mohaghegh; Zahra Ghayour-Najafabadi; Mehdi Azami; Farzaneh Mirzaei; Fatemeh Namdar; Mehdi Mohebali; Dhammika Leshan Wannigama; Seyed-Hossein Hejazi
Journal:  Iran J Parasitol       Date:  2020 Jan-Mar       Impact factor: 1.012

Review 5.  Opportunistic parasitic infections in patients with human immunodeficiency virus/acquired immunodeficiency syndrome: A review.

Authors:  D A Laksemi; L T Suwanti; M Mufasirin; K Suastika; M Sudarmaja
Journal:  Vet World       Date:  2020-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.